Skip to main content
Top
Published in: Rheumatology International 6/2021

01-06-2021 | Systemic Lupus Erythematosus | Observational Research

Poor maternal and foetal outcomes in women with systemic sclerosis: an interview-based study at a tertiary centre

Authors: Rajat Kharbanda, R. Naveen, Durga Prasanna Misra, Latika Gupta, Vikas Agarwal

Published in: Rheumatology International | Issue 6/2021

Login to get access

Abstract

Poor obstetric outcomes are described in rheumatic diseases (RDs) such as systemic sclerosis (SSc). We assessed the effect of the disease in Indian women and compared with those in developed countries and other RDs. Women with SSc (ACR/EULAR 2013 criteria) registered at a tertiary care centre (2010–2016) were interviewed by teleconsultation. Pregnancies occurring after disease onset were compared with those occurring prior to it. Maternal complications included antepartum hemorrhage, postpartum hemorrhage, spontaneous abortion, preterm rupture of membrane, oligohydramnios, infection, prolonged labour, and foetal complications including low birth weight (LBW), intrauterine death (IUD), preterm delivery, and neonatal infection. Results were expressed as median (Interquartile range). Of 200 SSc, 75 patients aged 31 (22–38) years and disease duration 41 (32–50) months were interviewed. Diffuse cutaneous SSc was the most common (42.56%). 127 conceptions before the onset of SSc were compared with 15 after. Among post-diagnosis, 9 (60%) were live births, 3 (20%) spontaneous abortions 1 (6.7%) induced abortion, 2 (13.3%) IUD. Of the live births, 4 (26.7%) were preterm and 3 (20%) were LBW. Pregnancies after disease onset had a higher rate of maternal (OR − 4.9) and foetal (OR − 9.9) complications compared to pregnancies before SSc. Compared to the Italian cohort, Indian SSc patients had a higher abortion rate (OR − 5.8), frequent lower section ceaserean section (OR − 9.4) and lower live births (OR − 0.05). More frequent caesarean deliveries (OR − 93), preterm deliveries (OR − 20) when compared with lupus and favourable maternal outcomes (OR − 0.15), higher preterm deliveries (OR − 9.6) in comparison with Takayasu arteritis were noted. SSc incurs a higher risk of poor maternal as well as the foetal outcome.
Appendix
Available only for authorised users
Literature
23.
go back to reference Wanchu A, Misra R (1996) Pregnancy outcome in systemic sclerosis. J Assoc Physicians India 44(9):637–640 (PMID: 9251376)PubMed Wanchu A, Misra R (1996) Pregnancy outcome in systemic sclerosis. J Assoc Physicians India 44(9):637–640 (PMID: 9251376)PubMed
26.
go back to reference Schmalzing M, Nau LF, Gernert M et al (2020) Sexual function in German women with systemic sclerosis compared to women with systemic lupus erythematosus and evaluation of a screening test. Clin Exp Rheumatol 38(125):59–64PubMed Schmalzing M, Nau LF, Gernert M et al (2020) Sexual function in German women with systemic sclerosis compared to women with systemic lupus erythematosus and evaluation of a screening test. Clin Exp Rheumatol 38(125):59–64PubMed
27.
go back to reference Singla S, Garg S, Attri B et al (2019) Contraceptive practices and awareness among patients attending a rheumatology clinic at a tertiary hospital in north India: a cross-sectional survey. J Indian Acad Clin Med 20:125 Singla S, Garg S, Attri B et al (2019) Contraceptive practices and awareness among patients attending a rheumatology clinic at a tertiary hospital in north India: a cross-sectional survey. J Indian Acad Clin Med 20:125
Metadata
Title
Poor maternal and foetal outcomes in women with systemic sclerosis: an interview-based study at a tertiary centre
Authors
Rajat Kharbanda
R. Naveen
Durga Prasanna Misra
Latika Gupta
Vikas Agarwal
Publication date
01-06-2021
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 6/2021
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-021-04793-8

Other articles of this Issue 6/2021

Rheumatology International 6/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.